Re: Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma

Affiliations

¹ Department of Urology, Bichat-Claude Bernard Hospital Paris Descartes University, Paris, France; Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy. Electronic address: gianl.califano2@gmail.com.
² Department of Urology, Bichat-Claude Bernard Hospital Paris Descartes University, Paris, France. Electronic address: evanguelosxylinas@hotmail.com.

Comment

Gianluigi Califano et al. Eur Urol. 2020 Jul.

. 2020 Jul;78(1):113-114.

doi: 10.1016/j.eururo.2020.04.008. Epub 2020 May 7.

¹ Department of Urology, Bichat-Claude Bernard Hospital Paris Descartes University, Paris, France; Urology Unit, Department of Neurosciences, Reproductive Sciences and Odontostomatology, Federico II University of Naples, Naples, Italy. Electronic address: gianl.califano2@gmail.com.
² Department of Urology, Bichat-Claude Bernard Hospital Paris Descartes University, Paris, France. Electronic address: evanguelosxylinas@hotmail.com.

No abstract available

Comment on

Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J; Collaborators. Margulis V, et al. J Urol. 2020 Apr;203(4):690-698. doi: 10.1097/JU.0000000000000644. Epub 2019 Nov 8. J Urol. 2020. PMID: 31702432 Free PMC article. Clinical Trial.